CP and nonischemic cardiomyopathy: In nonischemic cardiomyopathy patients, CP levels were significantly different among NYHA II, NYHA III, and NYHA IV groups (291.81 ± 56.28, 318.54 ± 91.98, and 375.03 ± 120.11, P < 0.05) (Figure 2).